Asian U15 & U17 Boxing: Indians Continue Strong Showing With Multiple Wins In Tashkent
In the U-15 boys' competition, Nongpoknganba Meitei Oina (46kg) secured a convincing 5:0 victory over Kazakhstan's Abdurakhman Vushanlo, while Parshant (49kg) mirrored the result with a dominant 5:0 win against Bakdaulet Akhmet.
Mohd Yasser (58kg) stood out with a commanding performance, sealing his bout via RSC in the first round against Kyrgyzstan's Akbarzhan Nabidzhanov. Nivesh Pal (54kg) also impressed with a 5:0 victory over Kazakhstan's Adilet Galiyev, while Ranveer (66kg) progressed after a walkover win against Chinese Taipei's Ying-Chieh Chen.
In other bouts, Lilmani Singh Lukram (61kg) went down via RSC in the third round against Uzbekistan's Azizbek Egamberganov, and Mehul Rana (70kg) suffered an RSC loss in the opening round against Kazakhstan's Ayan Bauyrzhan.
In the U-17 boys' evening session, Pal Nivesh (54kg) continued his strong form with another 5:0 win over Adilet Galiyev of Kazakhstan. Ranveer (66kg) registered a victory by ABD against Chinese Taipei's Ying-Chieh Chen. Lakshay Phogat (75kg) delivered a dominant display, clinching a first-round RSC win against Sri Lanka's Ranchigodagama Arachchila.
However, Pradeep (63kg) and Hanjra Jaideep Singh (80kg) faced tough opponents and went down 0:5 against Uzbekistan's Rushen Saydullaev and Kazakhstan's Alibek Alpamys, respectively.
With a mix of dominant wins and hard-fought bouts, the Indian contingent continues to showcase strong depth and promising talent across age groups as the championships progress in Tashkent.
Earlier, India's U-17 girls' boxers delivered a dominant start to their campaign at the Asian Boxing U17 Championships 2026, registering five impressive victories on Day 1 in Tashkent.
Rakhi (48kg) led the charge with a commanding performance, defeating her Sri Lankan opponent via RSC in the very first round. Continuing the strong momentum, Ovi (50kg) secured a unanimous 5–0 victory over Iran, while Mamta (52kg) outclassed her Thai opponent with another clinical 5–0 win.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment